Fig. 5

Exploitation and establishment of a USP2 differential prognostic model for the prediction of GC patients in TCGA. (A) Kaplan-Meier curves of OS for high- and low-GC subgroups. (B) ROC curves for 1-, 3-, and 5-years OS outcomes in accordance with the USP2 differential risk score. (C) Univariate and multivariate (D) Cox regression analyses were conducted to determine the associations of clinical features and the USP2-differential risk score with GC survival outcome. (E) A prognostic nomogram was exploited by integrating independent prognostic indicators (age, sex, and the USP2 differential risk score) to estimate the 1-, 3-, and 5-years survival probabilities. (F) Calibration plots showing the associations of the predicted 1-year OS with the actual survival duration.